An examination of the range of different trends and forces that are acting on the pharmaceutical sector – some of them well established, others only just emerging.
Analysts casting their eyes forward to 2022 see big pharma maintaining its position in the sector, protected by vast war chests and ready to pounce on any newcomer that shows promise.
New technologies are showing their worth in many areas of healthcare, such as providing education for doctors and patients, helping to explain what it is like to live with a condit
Japanese pharma group Eisai says it is battling a ransomware attack that was launched last weekend and has resulted in some of its servers becoming encrypted.
Health systems globally have reached a critical inflexion point, where ageing populations and tightening budgets mean we can no longer continue to purely treat late-stage symptomatic diseas